Get the Daily Brief
Latest Biotech News
FDA and EMA Scrutinize Sarepta’s Duchenne Gene Therapy
Sarepta Therapeutics faces intensified regulatory scrutiny following multiple patient deaths linked to its Duchenne muscular dystrophy gene therapy, Elevidys. The FDA is actively investigating an...
AstraZeneca’s Leadership and Strategic Moves
Bristol Myers Squibb appointed AstraZeneca's Cristian Massacesi as its new chief medical officer starting August 1, aiming to leverage his experience in oncology and rare diseases to bolster its...
AI Advancements in Immunotherapy and Cell Modeling
Researchers at Cold Spring Harbor Laboratory developed BATCAVE, a comprehensive database of over 22,000 TCR-peptide interactions, and an AI model named BATMAN that predicts T cell receptor...
Climate and Sustainability in Food and Agriculture
Recent studies highlight innovative approaches addressing climate change challenges and agricultural sustainability. Integration of renewable energy is enabling improved food sustainability in the...
Innovations in Flexible and Sustainable Electronics
Breakthroughs in materials science have advanced flexible and wearable electronics with robust, high-performance organic electrochemical transistors (OECTs) via electropolymerized PEDOT....
Oncology Advances: Lifestyle, Molecular Targets, and Clinical Guidelines
Growing evidence supports integrating lifestyle interventions into oncology practice, showing benefits in recurrence reduction, mortality improvements, and cost savings. Novel therapies emerge...
Parkinson’s Disease: Neurobiology and Novel Therapeutics
Recent research unveils key mechanisms of Parkinson’s disease, linking glymphatic system asymmetry to symptom lateralization, and distinguishing distinct pathways in nigral and cortical brain...
Biopharma Financing and Industry Trends
Biopharma fundraising remains robust, with significant capital raised in public and private financings year-to-date and substantial recent funds closing, including Brandon Capital's AU$439 million...
Genomics and Multiomics Innovations
Prominent leaders and researchers discuss advances in genomics and multiomics technologies, including spatial proteomics for precision oncology and scaling single-cell genomics projects to enhance...
Regulatory and Market Developments in Drug Approvals and Devices
Regulatory agencies continue making pivotal decisions affecting drug pipelines and medical devices. The EMA’s CHMP adopts five orphan drugs while rejecting Sarepta's Elevidys. Bayer's menopause...
Sarepta’s Elevidys Faces Regulatory Setbacks and Safety Concerns
Sarepta Therapeutics’ Duchenne muscular dystrophy gene therapy, Elevidys, is encountering significant regulatory and safety challenges in both Europe and the U.S. The European Medicines Agency's...
EMA Advances Alzheimer’s and HIV Therapies Amid Mixed Decisions
The European Medicines Agency's CHMP has shown support for Eli Lilly's Alzheimer’s drug Kisunla after reversing an earlier rejection, approving it for patients who are APOE4 heterozygotes or...
Biopharma Financing and Venture Capital Trends in 2025
Biopharma companies remain actively engaged in funding activities, with significant capital raised across public and private markets enhancing clinical and preclinical development pipelines....
Advancements in AI and Computational Tools Fueling Biotech Innovation
Recent breakthroughs in artificial intelligence are accelerating drug discovery, genomics, and immunotherapy development. A novel AI-powered model BATMAN outperforms existing tools in predicting T...
Leadership and Strategic Moves at Major Pharma Companies
Bristol Myers Squibb announced AstraZeneca’s Cristian Massacesi as new CMO, following a period of transformative oncology portfolio growth and pipeline expansion. Massacesi brings extensive...
Innovations in Cancer and Neurodegenerative Disease Therapeutics
Promising advances emerged in targeted therapies against various cancers and neurological diseases. Vepdegestrant, a PROTAC-based SERD, outperformed fulvestrant in mutant ER+ breast cancer models,...
Regulatory Shifts and Industry Challenges in Medical Devices and Pricing Policies
The global med-tech sector saw notable regulatory activity including FDA breakthrough designation granted to Cryofocus’ asthma cryoablation system. Meanwhile, policy shifts create a “pivotal...
Breakthroughs in Biomanufacturing and Materials Science
Recent scientific accomplishments include the development of durable, flexible organic electrochemical transistors using electropolymerized PEDOT, and a novel biodegradable conductive fiber...
Plant Immunity and Sustainable Agriculture Advances
Cutting-edge research revealed mechanisms in plant immunity and agricultural sustainability. Studies uncovered a root-based N-hydroxypipecolic acid circuit enhancing Arabidopsis immunity and...
Sarepta’s Duchenne Gene Therapy Faces Regulatory Setbacks and Safety Scrutiny
Sarepta Therapeutics’ Duchenne muscular dystrophy gene therapy, Elevidys, is under intense regulatory and market pressure. The European Medicines Agency’s Committee for Medicinal Products for...